$MDNA, $NMTR, and $ELOX

Expectations and predictions for smid-cap bios with upcoming Q4 catalysts

Below are several updates on names that have upcoming Q4 catalysts. We expect Medicenna ($MDNA) data in December 2021, 9Meter ($NMTR) and Eloxx ($ELOX) in November 2021. 

MDNA11 Doses First Patient
Earlier this week, Medicenna announced dosing the first patient in their Phase 1 trial in Australia, called the “ABILITY” study. This was an important mileston…